Clinical Trials Browser

Phase 3 × Peritoneal Neoplasms × 1 year × Clear all

NCT03740165 2025-10-22

KEYLYNK-001

Phase 3 Active not recruiting

1,367 enrolled 29 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT04111978 2025-09-29

MATAO

Phase 3 Recruiting

Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT06839092 2025-07-30

PROPAC

Phase 3 Not yet recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT03348150 2025-07-17

PERISCOPEII

Phase 3 Active not recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT04498117 2025-07-09

FLORA-5

Phase 3 Active not recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT05257408 2025-04-16

Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer

Phase 3 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms